Meclizine HCl Tablets, USP, 25 mg, 100 Tablets bottles, Rx Only, Mfd. for: Wilshire…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Recalling firm

Wilshire Pharmaceuticals Inc

NDC code

52536-133-01

Origin

GA, United States

Initiated by

Voluntary: Firm initiated

FDA recall number

D-0259-2021

Other Meclizine recalls

See all

Class II · Moderate risk Ongoing Mar 16, 2026

Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC…

Reason Failed tablet specifications.

Amerisource Health Services LLC NDC 60687-775-65 D-0418-2026

Class II · Moderate risk Terminated Apr 13, 2022

Meclizine Hydrochloride Tablets, USP, 25 mg, 50-count cartons (5 x10 unit dose), 10 Tablets per card, 5 cards per carton, Rx…

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 50268-523-15 D-1037-2022

Class I · High risk Terminated Mar 8, 2022

Meclizine Hydrochloride Tablets USP, 12.5 mg, packaged in a case of 24 bottles (100-count bottle), Rx only, Manufactured by…

Reason Labeling: Label mix-up: Incorrect label placed on product. Shipper cases labeled Meclizine Hydrochloride Tablets contain bottles incorrectly labeled…

Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-122-06 D-0767-2022

Class II · Moderate risk Ongoing Sep 2, 2021

Meclizine HCl Tablets, 25 mg, packaged in 100-count HDPE bottle, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ…

Reason Labeling: Incorrect Instructions

Rising Pharmaceuticals NDC 16571-752-01 D-0005-2022

Class II · Moderate risk Terminated Feb 4, 2021

Meclizine HCl Tablets, USP, 12.5 mg, 100 Tablets bottles, Rx Only, Mfd. for: Wilshire Pharmaceuticals, Inc., Atlanta, GA 30328…

Reason Failed Dissolution Specifications

Wilshire Pharmaceuticals Inc NDC 52536-129-01 D-0258-2021